Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation

NCT01002339 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

134

Enrollment

OTHER

Sponsor class

Stopped Terminated: higher rate of acute rejection in the Cyclosporin A group

Conditions

Diabetes Mellitus, Adult-Onset

Interventions

DRUG: Tacrolimus with rapid steroid withdrawal
DRUG: Tacrolimus with steroids minimization
DRUG: CsA with steroid minimization

Sponsor

Armando Torres Ramírez